(Q36684205)

15 August 2017

1 reference

title

PPAR delta agonists and metabolic diseases (English)

1 reference

15 August 2017

Kihwa Kang

1

1 reference

PubMed ID

17169250

15 August 2017

Ben Hatano

series ordinal

2

1 reference

PubMed ID

17169250

15 August 2017

Chih-Hao Lee

series ordinal

3

1 reference

15 August 2017

1 January 2007

1 reference

Current Atherosclerosis Reports

15 August 2017

1 reference

15 August 2017

9

1 reference

15 August 2017

1

1 reference

15 August 2017

72-77

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02693931

15 August 2017

0 references

cites work

Peroxisome proliferator-activated receptors: nuclear control of metabolism

1 reference

12 December 2020

Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome

1 reference

12 December 2020

Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity

1 reference

12 December 2020

Effects of peroxisome proliferator-activated receptor alpha/delta agonists on HDL-cholesterol in vervet monkeys

1 reference

12 December 2020

Peroxisome proliferator-activated receptor beta/delta regulates very low density lipoprotein production and catabolism in mice on a Western diet.

1 reference

12 December 2020

GW-501516 GlaxoSmithKline/Ligand.

1 reference

12 December 2020

PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

1 reference

12 December 2020

PPAR gamma is required for placental, cardiac, and adipose tissue development

1 reference

12 December 2020

Nuclear receptors and lipid physiology: opening the X-files

1 reference

12 December 2020

The PPARdelta agonist GW0742X reduces atherosclerosis in LDLR(-/-) mice

1 reference

12 December 2020

Transcriptional repression of atherogenic inflammation: modulation by PPARdelta

1 reference

12 December 2020

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

12 December 2020

A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders

1 reference

12 December 2020

Regulation of muscle fiber type and running endurance by PPARdelta

1 reference

12 December 2020

Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay

1 reference

12 December 2020

Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)

1 reference

12 December 2020

The nuclear receptor superfamily: the second decade

1 reference

12 December 2020

Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes

1 reference

12 December 2020

Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activity

1 reference

12 December 2020

Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting

1 reference

12 December 2020

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

1 reference

12 December 2020

Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma

1 reference

12 December 2020

PPARdelta regulates glucose metabolism and insulin sensitivity

1 reference

12 December 2020

Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer

1 reference

12 December 2020

Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes

1 reference

12 December 2020

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

1 reference

12 December 2020

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

12 December 2020

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

1 reference

12 December 2020

Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy

1 reference

12 December 2020

Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors

1 reference

12 December 2020

Activation of PPARdelta alters lipid metabolism in db/db mice.

1 reference

12 December 2020

Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men.

1 reference

12 December 2020

Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability

1 reference

12 December 2020

Genetic polymorphisms in peroxisome proliferator-activated receptor delta associated with obesity

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02693931

1 reference

15 August 2017

1 reference

PubMed ID

17169250